HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jamie R Wood Selected Research

Type 1 Diabetes Mellitus (Autoimmune Diabetes)

2/2022Psychological Characteristics and Goals of Caregivers Choosing Continuous Glucose Monitoring for Children With Type 1 Diabetes.
1/2022Safety and Glycemic Outcomes With a Tubeless Automated Insulin Delivery System in Very Young Children With Type 1 Diabetes: A Single-Arm Multicenter Clinical Trial.
11/2021Diabetes technologies for children and adolescents with type 1 diabetes are highly dependent on coverage and reimbursement: results from a worldwide survey.
2/2017Clinical and Psychosocial Outcomes of a Structured Transition Program Among Young Adults With Type 1 Diabetes.
12/2016Vitamin D status in youth with type 1 and type 2 diabetes enrolled in the Pediatric Diabetes Consortium (PDC) is not worse than in youth without diabetes.
6/2014Pediatric Diabetes Consortium Type 1 Diabetes New Onset (NeOn) Study: factors associated with HbA1c levels one year after diagnosis.
11/2013Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes.
8/2013Incretins and amylin in pediatric diabetes: new tools for management of diabetes in youth.
7/2013Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines.
5/2012Evaluation of 1,5-anhydroglucitol, hemoglobin A1c, and glucose levels in youth and young adults with type 1 diabetes and healthy controls.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jamie R Wood Research Topics

Disease

13Type 1 Diabetes Mellitus (Autoimmune Diabetes)
02/2022 - 11/2006
4Hypoglycemia (Reactive Hypoglycemia)
01/2022 - 08/2015
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 08/2013
3Dyslipidemias (Dyslipidemia)
01/2017 - 06/2011
1Congenital Hyperinsulinism
02/2021
1Non-alcoholic Fatty Liver Disease
01/2017
1Permanent Neonatal Diabetes Mellitus
01/2017
1Hypertension (High Blood Pressure)
01/2017
1Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
06/2014
1Insulin Resistance
08/2013
1Pediatric Obesity
08/2013
1Stroke (Strokes)
06/2011

Drug/Important Bio-Agent (IBA)

6Insulin (Novolin)FDA Link
01/2022 - 11/2006
4Glucose (Dextrose)FDA LinkGeneric
02/2022 - 05/2012
3Hemoglobins (Hemoglobin)IBA
02/2017 - 05/2012
2Vitamin DFDA LinkGeneric
12/2016 - 01/2009
2LipidsIBA
07/2013 - 06/2011
1Dihydroxyphenylalanine (Dopa)IBA
02/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
01/2017
1antiarrhythmic peptide (AAP)IBA
05/2015
1AutoantibodiesIBA
06/2014
1Short-Acting InsulinIBA
08/2013
1Glucagon-Like Peptide 1 (GLP 1)IBA
08/2013
1Dipeptidyl-Peptidase IV InhibitorsIBA
08/2013
1Exenatide (Byetta)FDA Link
08/2013
1LiraglutideFDA Link
08/2013
11,5-anhydroglucitolIBA
05/2012
1oxidized low density lipoproteinIBA
06/2011
125-hydroxyvitamin DIBA
01/2009

Therapy/Procedure

3Glycemic Control
01/2018 - 06/2011
2Therapeutics
11/2013 - 08/2013
1Occupational Therapy (Therapy, Occupational)
01/2018
1Transition to Adult Care
02/2017
1Injections
01/2017